Download a Free Sample COVID-19 Report
The enzyme-linked immunosorbent assay (ELISA) market will experience a neutral impact during the forecast period due to the widespread growth of the COVID-19 pandemic. According to Technavio’s pandemic-focused market research, the market growth is expected to increase in 2021 compared to 2020.
With the continued spread of the novel coronavirus pandemic, organizations around the world are gradually flattening their recession curves by taking advantage of technology. Many businesses will go through phases of response, recovery and renewal. Building business resilience and agility will help organizations move forward from the COVID-19 crisis to the next normal.
This post-pandemic business planning research will help customers:
- Adjust their strategic planning to move forward once the stability of the business is in place.
- Build resilience by make efficient resource and investment choices for individual business units, products and service lines.
- Conceptualize scenario-based planning to mitigate future crisis situations.
Download the post-pandemic planning structure
Key considerations for market forecast:
- Impact of bottlenecks, supply chain disruptions, destruction of demand and changing customer behavior
- Optimistic, probable and pessimistic scenarios for all markets as the impact of the pandemic unfolds
- Market estimates before and after COVID-19
- Quarterly impact analysis and update of market estimates
Instantly access over 17,000 market research reports using
Technavio SUBSCRIPTION platform
Related report on healthcare industries:
Genetic Panels Market by Product and Geography – Forecast and Analysis 2021-2025
Influenza Diagnostics Market by End User, Type and Geography – Forecast and Analysis 2021-2025
Cannabis Testing Market by Product and Geography – Forecast and Analysis 2021-2025
Direct-to-Consumer Genetic Testing Market by Distribution Channel, Service, and Geography – Forecast and Analysis 2021-2025
The top three players in the Enzyme-linked Immunosorbent Assay (ELISA) market:
In December 2019, the company announced a partnership with SomaServe Ltd. (SomaServe) to commercialize the potential for cellular delivery of polymer-based bionic nanoparticles.
Bio-Rad Laboratories inc.
In april 2020, the company announced the acquisition of Celsee Inc., a company that provides consumables and instruments for the isolation, detection and analysis of single cells. In april 2020, the company announced the launch of a blood-based immunoassay kit to perform a serological test to identify antibodies to the coronavirus SARS-CoV-2.
Becton, Dickinson et Cie.
In February 2020, the company announced a long-term strategic partnership agreement with Babson Diagnostics to bring laboratory-grade, small-volume blood collection to retail pharmacies. In November 2019, the company launched enhanced analytical capabilities for antimicrobial stewardship.
If you purchase an updated report within the next 60 days, we’ll send you the new edition and the data extract for FREE! Get an overview of the report here to get a detailed market share analysis of market players during the COVID-19 lockdown:
Enzyme-Linked Immunosorbent Assay (ELISA) market 2021-2025: Segmentation
The Enzyme-linked Immunosorbent Assay (ELISA) market is segmented as follows:
- Final user
- Hospitals and diagnostic centers
- Research laboratories
- North America
The enzyme-linked immunosorbent assay (ELISA) market is driven by the growing need for frequent diagnostic testing among the aging population, the increase in toxicology testing in the food industry and the increase in chronic diseases. Additionally, other factors such as those expected to trigger the enzyme-linked immunosorbent assay (ELISA) market towards a CAGR of over around 9% during the forecast period.
Get more insight into global trends impacting the future of the Enzyme-Linked immunosorbent assay (ELISA) market, request a free sample @ https://www.technavio.com/talk-to-us?report=IRTNTR41149
- Covered suppliers
- Supplier ranking
- Positioning of sellers in the market
- Competitive scenario
Technavio is one of the world’s leading technology research and consulting companies. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s report library includes over 17,000+ reports, spanning 800 technologies, spanning 50 countries. Their customer base consists of companies of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research and actionable market intelligence to identify opportunities in existing markets. and potentials and assess their competitive positions in changing market scenarios.
Communication and Marketing Officer
United States: +1 844 364 1100
United Kingdom: +44 203 893 3200
E-mail: [email protected]
http: // https://www.technavio.com/report/enzyme-linked-immunosorbent-assay-market-industry-analysis